Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultraviolet Rays | 50 | 2015 | 198 | 3.380 |
Why?
|
| Neoplasms, Radiation-Induced | 34 | 2010 | 81 | 2.120 |
Why?
|
| Dietary Fats | 18 | 2015 | 279 | 1.840 |
Why?
|
| Skin Neoplasms | 34 | 2015 | 897 | 1.790 |
Why?
|
| Antioxidants | 24 | 2015 | 333 | 1.780 |
Why?
|
| beta Carotene | 10 | 2010 | 34 | 1.290 |
Why?
|
| Anticarcinogenic Agents | 7 | 2010 | 48 | 1.170 |
Why?
|
| Fatty Acids, Omega-3 | 6 | 2020 | 74 | 1.020 |
Why?
|
| Skin | 23 | 1996 | 527 | 0.630 |
Why?
|
| Ascorbic Acid | 7 | 2010 | 76 | 0.630 |
Why?
|
| Hyperlipidemias | 1 | 2020 | 188 | 0.610 |
Why?
|
| Butylated Hydroxytoluene | 11 | 2004 | 12 | 0.600 |
Why?
|
| Carotenoids | 5 | 2007 | 79 | 0.520 |
Why?
|
| Mice, Hairless | 21 | 2003 | 30 | 0.510 |
Why?
|
| Free Radicals | 8 | 2005 | 33 | 0.490 |
Why?
|
| Dietary Supplements | 6 | 2015 | 439 | 0.450 |
Why?
|
| Lipids | 5 | 2015 | 561 | 0.450 |
Why?
|
| Carcinogens | 8 | 2010 | 128 | 0.430 |
Why?
|
| Diet | 12 | 2015 | 1125 | 0.410 |
Why?
|
| Radiation-Protective Agents | 5 | 2004 | 19 | 0.400 |
Why?
|
| Tocopherols | 1 | 2010 | 7 | 0.340 |
Why?
|
| Lipid Peroxidation | 3 | 2006 | 93 | 0.330 |
Why?
|
| Vitamin E | 7 | 2004 | 63 | 0.320 |
Why?
|
| Animals | 59 | 2020 | 34823 | 0.310 |
Why?
|
| Mice | 44 | 2020 | 18488 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2005 | 633 | 0.300 |
Why?
|
| Fish Oils | 6 | 2020 | 80 | 0.290 |
Why?
|
| Sunlight | 3 | 1998 | 26 | 0.280 |
Why?
|
| Oxidants | 2 | 2004 | 25 | 0.270 |
Why?
|
| Diet, Fat-Restricted | 2 | 1998 | 40 | 0.260 |
Why?
|
| Reactive Oxygen Species | 3 | 2004 | 516 | 0.250 |
Why?
|
| Cocarcinogenesis | 3 | 1995 | 15 | 0.250 |
Why?
|
| Epidermis | 6 | 2000 | 64 | 0.240 |
Why?
|
| Fatty Acids, Unsaturated | 6 | 2006 | 65 | 0.230 |
Why?
|
| Photosensitivity Disorders | 1 | 2004 | 11 | 0.220 |
Why?
|
| Cholesterol | 11 | 1980 | 559 | 0.200 |
Why?
|
| Neoplasms, Experimental | 10 | 1995 | 218 | 0.190 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 53 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 1998 | 764 | 0.180 |
Why?
|
| Trout | 1 | 2020 | 1 | 0.170 |
Why?
|
| Eels | 1 | 2020 | 2 | 0.170 |
Why?
|
| Ornithine Decarboxylase | 5 | 1994 | 18 | 0.170 |
Why?
|
| Sulfonamides | 1 | 2002 | 283 | 0.160 |
Why?
|
| Random Allocation | 4 | 2003 | 431 | 0.160 |
Why?
|
| Carcinoma | 2 | 2007 | 300 | 0.150 |
Why?
|
| Models, Chemical | 3 | 2006 | 88 | 0.150 |
Why?
|
| Haptens | 1 | 1998 | 7 | 0.150 |
Why?
|
| Oxidation-Reduction | 5 | 2010 | 436 | 0.140 |
Why?
|
| Light | 4 | 2006 | 183 | 0.140 |
Why?
|
| Antibody Formation | 1 | 1998 | 274 | 0.130 |
Why?
|
| Neoplasms | 4 | 2004 | 2952 | 0.130 |
Why?
|
| Carcinogenicity Tests | 3 | 2003 | 20 | 0.120 |
Why?
|
| Keratosis | 2 | 1994 | 17 | 0.120 |
Why?
|
| DNA | 3 | 1997 | 1478 | 0.110 |
Why?
|
| Immune Tolerance | 1 | 1995 | 153 | 0.110 |
Why?
|
| Enzyme Induction | 5 | 1994 | 97 | 0.110 |
Why?
|
| Skin Aging | 1 | 1994 | 12 | 0.110 |
Why?
|
| PUVA Therapy | 2 | 1994 | 4 | 0.100 |
Why?
|
| Carcinoma, Basal Cell | 1 | 1994 | 69 | 0.100 |
Why?
|
| Humans | 28 | 2015 | 132055 | 0.100 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 1992 | 32 | 0.100 |
Why?
|
| Lipid Peroxides | 3 | 1987 | 15 | 0.100 |
Why?
|
| Eicosanoids | 1 | 1991 | 13 | 0.090 |
Why?
|
| Membrane Lipids | 1 | 1991 | 31 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2007 | 1670 | 0.090 |
Why?
|
| Dinoprostone | 3 | 2002 | 70 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 1994 | 278 | 0.090 |
Why?
|
| Female | 32 | 2003 | 70691 | 0.090 |
Why?
|
| Glass | 1 | 1990 | 11 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2005 | 801 | 0.080 |
Why?
|
| Plastics | 1 | 1990 | 14 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 1990 | 3043 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 1991 | 1829 | 0.070 |
Why?
|
| Energy Intake | 2 | 2004 | 493 | 0.070 |
Why?
|
| Cell Survival | 2 | 1990 | 868 | 0.070 |
Why?
|
| Incidence | 3 | 2003 | 3370 | 0.070 |
Why?
|
| Culture Media | 3 | 1990 | 182 | 0.070 |
Why?
|
| Time Factors | 7 | 2007 | 6442 | 0.070 |
Why?
|
| Smoking | 2 | 2004 | 940 | 0.070 |
Why?
|
| Lutein | 1 | 2007 | 14 | 0.070 |
Why?
|
| Sunscreening Agents | 1 | 1986 | 4 | 0.060 |
Why?
|
| Vegetables | 2 | 2001 | 273 | 0.060 |
Why?
|
| Phenols | 1 | 1986 | 57 | 0.060 |
Why?
|
| Dinitrochlorobenzene | 1 | 1985 | 2 | 0.060 |
Why?
|
| Nitrobenzenes | 1 | 1985 | 15 | 0.060 |
Why?
|
| Fatty Acids, Omega-6 | 3 | 1994 | 18 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2004 | 246 | 0.050 |
Why?
|
| DNA Damage | 2 | 1997 | 511 | 0.050 |
Why?
|
| Singlet Oxygen | 2 | 2001 | 2 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2004 | 179 | 0.050 |
Why?
|
| Oils | 1 | 1983 | 5 | 0.050 |
Why?
|
| Inflammation | 2 | 2006 | 1522 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2003 | 111 | 0.050 |
Why?
|
| Cholesterol, Dietary | 2 | 1997 | 48 | 0.050 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2004 | 143 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 1991 | 1757 | 0.050 |
Why?
|
| Celecoxib | 1 | 2002 | 32 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 673 | 0.050 |
Why?
|
| Rats | 2 | 2007 | 3604 | 0.050 |
Why?
|
| Epoxide Hydrolases | 2 | 1979 | 37 | 0.050 |
Why?
|
| Probability | 1 | 2002 | 322 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 234 | 0.040 |
Why?
|
| Mice, Nude | 5 | 1984 | 754 | 0.040 |
Why?
|
| Ethers, Cyclic | 3 | 1976 | 13 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 437 | 0.040 |
Why?
|
| Partial Pressure | 1 | 2001 | 28 | 0.040 |
Why?
|
| Selenium | 1 | 2001 | 15 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2001 | 161 | 0.040 |
Why?
|
| Carboxy-Lyases | 1 | 1980 | 13 | 0.040 |
Why?
|
| 2-Acetylaminofluorene | 1 | 1980 | 1 | 0.040 |
Why?
|
| Sterilization | 1 | 1980 | 6 | 0.040 |
Why?
|
| Corynebacterium | 1 | 1980 | 12 | 0.040 |
Why?
|
| Filtration | 1 | 1980 | 22 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1160 | 0.040 |
Why?
|
| Corn Oil | 3 | 1992 | 10 | 0.040 |
Why?
|
| Mutagens | 1 | 1980 | 48 | 0.040 |
Why?
|
| Interferons | 1 | 1981 | 142 | 0.040 |
Why?
|
| Radiation Effects | 6 | 1976 | 12 | 0.040 |
Why?
|
| Oxygen | 2 | 2001 | 569 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2002 | 329 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 590 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2007 | 2509 | 0.040 |
Why?
|
| Epoxy Compounds | 2 | 1976 | 19 | 0.040 |
Why?
|
| Disease Progression | 1 | 2005 | 2232 | 0.040 |
Why?
|
| Picrates | 1 | 1998 | 3 | 0.040 |
Why?
|
| Radiation Injuries, Experimental | 2 | 1978 | 23 | 0.040 |
Why?
|
| Xanthophylls | 1 | 1998 | 3 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 5 | 1979 | 45 | 0.030 |
Why?
|
| Sheep | 1 | 1998 | 229 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 1997 | 35 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1577 | 0.030 |
Why?
|
| Rodentia | 1 | 1997 | 46 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1998 | 201 | 0.030 |
Why?
|
| DNA Adducts | 1 | 1997 | 72 | 0.030 |
Why?
|
| DNA Repair | 2 | 1997 | 567 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 1998 | 241 | 0.030 |
Why?
|
| Edible Grain | 1 | 1997 | 45 | 0.030 |
Why?
|
| Methoxsalen | 1 | 1996 | 1 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1997 | 209 | 0.030 |
Why?
|
| Spectrophotometry | 2 | 1996 | 56 | 0.030 |
Why?
|
| Food Additives | 1 | 1996 | 5 | 0.030 |
Why?
|
| Risk Factors | 2 | 2004 | 10936 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1996 | 221 | 0.030 |
Why?
|
| Fatty Acids | 3 | 1993 | 356 | 0.030 |
Why?
|
| Fruit | 1 | 1997 | 234 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1996 | 347 | 0.030 |
Why?
|
| Hydro-Lyases | 1 | 1974 | 9 | 0.030 |
Why?
|
| Point Mutation | 1 | 1996 | 349 | 0.030 |
Why?
|
| Prognosis | 1 | 2004 | 5013 | 0.030 |
Why?
|
| Mitotic Index | 1 | 1994 | 17 | 0.030 |
Why?
|
| Chromatography, Gas | 3 | 1985 | 21 | 0.030 |
Why?
|
| Brevibacterium | 1 | 1993 | 1 | 0.030 |
Why?
|
| Piedra | 1 | 1993 | 1 | 0.030 |
Why?
|
| Trichosporon | 1 | 1993 | 5 | 0.030 |
Why?
|
| Hair | 1 | 1993 | 28 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1994 | 277 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1998 | 1249 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2001 | 3414 | 0.030 |
Why?
|
| Atrophy | 1 | 1994 | 251 | 0.030 |
Why?
|
| Melanoma | 1 | 2001 | 954 | 0.030 |
Why?
|
| Mutagenicity Tests | 2 | 1985 | 20 | 0.030 |
Why?
|
| Photochemistry | 4 | 1980 | 21 | 0.020 |
Why?
|
| Sterols | 4 | 1974 | 17 | 0.020 |
Why?
|
| Middle Aged | 5 | 1997 | 28979 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 1992 | 17 | 0.020 |
Why?
|
| Erythema | 1 | 1992 | 29 | 0.020 |
Why?
|
| Carbon Isotopes | 4 | 1973 | 233 | 0.020 |
Why?
|
| Erythrocyte Membrane | 1 | 1991 | 22 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 4683 | 0.020 |
Why?
|
| Glutathione | 4 | 1978 | 200 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1994 | 584 | 0.020 |
Why?
|
| Odds Ratio | 1 | 1994 | 1255 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 1977 | 68 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 1540 | 0.020 |
Why?
|
| RNA | 1 | 1994 | 549 | 0.020 |
Why?
|
| Luminescence | 1 | 1990 | 18 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2001 | 6556 | 0.020 |
Why?
|
| Liver | 3 | 1986 | 1797 | 0.020 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 1 | 1989 | 10 | 0.020 |
Why?
|
| Logistic Models | 1 | 1994 | 1836 | 0.020 |
Why?
|
| Acetates | 3 | 1974 | 80 | 0.020 |
Why?
|
| Phospholipids | 3 | 1974 | 104 | 0.020 |
Why?
|
| Psoriasis | 1 | 1988 | 48 | 0.020 |
Why?
|
| Citrus paradisi | 1 | 2007 | 1 | 0.020 |
Why?
|
| Aging | 1 | 1994 | 1252 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2002 | 13015 | 0.020 |
Why?
|
| Male | 7 | 2007 | 64944 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 351 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 1045 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1985 | 43 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1985 | 67 | 0.010 |
Why?
|
| Cell Line | 1 | 1990 | 2723 | 0.010 |
Why?
|
| Chemistry | 1 | 1984 | 54 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 5407 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1984 | 82 | 0.010 |
Why?
|
| Toluene | 2 | 1974 | 11 | 0.010 |
Why?
|
| Photolysis | 2 | 1973 | 12 | 0.010 |
Why?
|
| Mutation | 1 | 1997 | 6246 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2001 | 17367 | 0.010 |
Why?
|
| Coenzyme A | 2 | 1973 | 6 | 0.010 |
Why?
|
| DNA Replication | 1 | 1984 | 353 | 0.010 |
Why?
|
| Mevalonic Acid | 2 | 1973 | 20 | 0.010 |
Why?
|
| Body Weight | 1 | 1985 | 995 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1972 | 861 | 0.010 |
Why?
|
| Carbonates | 1 | 1980 | 7 | 0.010 |
Why?
|
| Cricetinae | 2 | 1980 | 381 | 0.010 |
Why?
|
| Esters | 1 | 1980 | 35 | 0.010 |
Why?
|
| Biotransformation | 1 | 1980 | 56 | 0.010 |
Why?
|
| Cellulose | 1 | 1980 | 27 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1980 | 100 | 0.010 |
Why?
|
| Polymers | 1 | 1980 | 108 | 0.010 |
Why?
|
| Adult | 3 | 1997 | 31557 | 0.010 |
Why?
|
| Radiochemistry | 1 | 1979 | 3 | 0.010 |
Why?
|
| Sunburn | 1 | 1978 | 4 | 0.010 |
Why?
|
| Phenobarbital | 1 | 1978 | 32 | 0.010 |
Why?
|
| Disulfiram | 1 | 1978 | 33 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1977 | 86 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 70 | 0.010 |
Why?
|
| Codon | 1 | 1996 | 98 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 52 | 0.010 |
Why?
|
| Pulse Radiolysis | 1 | 1996 | 1 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1996 | 60 | 0.010 |
Why?
|
| Lysosomes | 1 | 1977 | 261 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 68 | 0.010 |
Why?
|
| Glycerides | 1 | 1974 | 16 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1973 | 37 | 0.010 |
Why?
|
| Tellurium | 1 | 1993 | 2 | 0.010 |
Why?
|
| Ribose | 1 | 1993 | 13 | 0.010 |
Why?
|
| Base Composition | 1 | 1993 | 74 | 0.010 |
Why?
|
| Genitalia | 1 | 1993 | 38 | 0.010 |
Why?
|
| Butyrates | 1 | 1973 | 42 | 0.010 |
Why?
|
| Cell Wall | 1 | 1993 | 41 | 0.010 |
Why?
|
| Species Specificity | 1 | 1974 | 542 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1974 | 304 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1974 | 275 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 1554 | 0.010 |
Why?
|
| Cholestanes | 1 | 1972 | 1 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 2669 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 2897 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1996 | 770 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1993 | 232 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1993 | 494 | 0.010 |
Why?
|
| Fats | 1 | 1971 | 12 | 0.010 |
Why?
|
| Xenon | 1 | 1971 | 12 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1971 | 75 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1972 | 382 | 0.000 |
Why?
|
| Leukotriene B4 | 1 | 1988 | 8 | 0.000 |
Why?
|
| Swine | 1 | 1971 | 1179 | 0.000 |
Why?
|
| Models, Biological | 1 | 1972 | 1443 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1993 | 2551 | 0.000 |
Why?
|
| Cricetulus | 1 | 1980 | 93 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1980 | 441 | 0.000 |
Why?
|
| Administration, Topical | 1 | 1978 | 140 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1978 | 699 | 0.000 |
Why?
|